myelodysplastic syndrom
Conditions
Sponsors
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients aged 18-80 years (calculated by date of birth); (2) The diagnostic criteria of MDS in Vienna in 2006 were met, (3) IPSS risk score was low / medium risk-1 (<= 1.0), and ipss-r was extremely low-risk / low-risk / medium risk (<= 3.5); (4) Patients who met the diagnostic criteria of kidney yang deficiency syndrome; (5)HGB<100g/L; (6) No other drugs that may affect hematopoietic function were used for 3 months or more; (7) The subjects were volunteers and informed consent was signed.
Exclusion criteria
Exclusion criteria: (1) Pregnant and lactating women; (2) Those with allergic constitution are allergic to the test drug or its related drugs or ingredients; (3) Patients with severe primary diseases such as heart, cerebrovascular, liver and kidney diseases; (4) Patients with severe liver function damage had ALT or AST >= 1.5 times of the upper limit of normal value; (5) In patients with severe renal impairment, serum creatinine was more than 1.5 times of the upper limit of normal value; (6) Mental illness patients who can't cooperate with each other; (7) Those who are participating in other clinical trials or have participated in other drug clinical trials within 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HI-E;HI-N/HI-P;SF-36;TCM syndrome; | — |
Countries
China
Contacts
Public ContactWeiYing Qu
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed